- Home
- GSM vs DNTH Comparison
GSM vs DNTH Comparison
Compare GSM & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSM
- DNTH
- Stock Information
- Founded
- GSM 2015
- DNTH 2015
- Country
- GSM United Kingdom
- DNTH United States
- Employees
- GSM N/A
- DNTH N/A
- Industry
- GSM Metal Mining
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- GSM Basic Materials
- DNTH Health Care
- Exchange
- GSM Nasdaq
- DNTH Nasdaq
- Market Cap
- GSM 731.6M
- DNTH 606.2M
- IPO Year
- GSM N/A
- DNTH N/A
- Fundamental
- Price
- GSM $4.34
- DNTH $18.94
- Analyst Decision
- GSM Hold
- DNTH Strong Buy
- Analyst Count
- GSM 1
- DNTH 8
- Target Price
- GSM N/A
- DNTH $53.00
- AVG Volume (30 Days)
- GSM 2.3M
- DNTH 353.3K
- Earning Date
- GSM 08-04-2025
- DNTH 08-07-2025
- Dividend Yield
- GSM 1.29%
- DNTH N/A
- EPS Growth
- GSM N/A
- DNTH N/A
- EPS
- GSM N/A
- DNTH N/A
- Revenue
- GSM $1,559,264,000.00
- DNTH $6,524,000.00
- Revenue This Year
- GSM N/A
- DNTH N/A
- Revenue Next Year
- GSM $11.34
- DNTH N/A
- P/E Ratio
- GSM N/A
- DNTH N/A
- Revenue Growth
- GSM N/A
- DNTH 102.36
- 52 Week Low
- GSM $2.97
- DNTH $13.37
- 52 Week High
- GSM $6.11
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- GSM 56.70
- DNTH 56.88
- Support Level
- GSM $4.26
- DNTH $17.88
- Resistance Level
- GSM $4.58
- DNTH $20.86
- Average True Range (ATR)
- GSM 0.19
- DNTH 1.34
- MACD
- GSM 0.04
- DNTH 0.25
- Stochastic Oscillator
- GSM 70.56
- DNTH 44.81
About GSM Ferroglobe PLC
Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.